Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Pediatric Oncology
What is the optimal salvage therapy for a patient with a relapsed primary mediastinal yolk sac tumor with brain metastases?
Optimal salvage chemotherapy?
Role/type of transplant?
Role for RT?
Role for surgery/neurosurgery?
Related Questions
Would you offer adjuvant radiation therapy in a young adult with NF1 who has a craniopharyngioma s/p STR?
How will you treat an uterine embryonal rhabdomyosarcoma with regional node involvement resected to involved parametrial margins?
In which settings would you use external beam radiotherapy for retinoblastoma in the upfront (new diagnosis) setting?
How do you differentiate demoralization from depression during cancer treatment?
For patients with Stage IIIB or IV HD flowing Bv-AVEPC with initial large mediastinal adenopathy, how can we avoid ISRT?
In a patients with bilateral Wilms' tumor with favorable features (>90% response to VAD, no anaplasia), what histopathologic criteria should be used to define a positive margin requiring focal RT to a partial nephrectomy bed?
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
What cochlea dose constraint (if any) would you use when treating an acoustic neuroma without serviceable hearing on that side?
Why do the most recent NCCN guidelines (Version 4.2024, 05/17/24) omit the duration of ADT for high-risk prostate cancer patients?